450 related articles for article (PubMed ID: 23726147)
21. Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases.
Conejo MC; Hernández JR; Pascual A
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):343-5. PubMed ID: 18339509
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae.
Crémieux AC; Dinh A; Nordmann P; Mouton W; Tattevin P; Ghout I; Jayol A; Aimer O; Gatin L; Verdier MC; Saleh-Mghir A; Laurent F
J Antimicrob Chemother; 2019 Sep; 74(9):2666-2675. PubMed ID: 31263884
[TBL] [Abstract][Full Text] [Related]
23. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing
Ojdana D; Gutowska A; Sacha P; Majewski P; Wieczorek P; Tryniszewska E
Microb Drug Resist; 2019 Nov; 25(9):1357-1364. PubMed ID: 31295055
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of colistin sulfate against Enterobacteriaceae producing extended-spectrum β-lactamases.
Ku YH; Lee MF; Chuang YC; Chen CC; Yu WL
J Microbiol Immunol Infect; 2015 Dec; 48(6):699-702. PubMed ID: 24388585
[TBL] [Abstract][Full Text] [Related]
25. Clonal Spread of Colistin-Resistant Klebsiella pneumoniae Coproducing KPC and VIM Carbapenemases in Neonates at a Tunisian University Hospital.
Battikh H; Harchay C; Dekhili A; Khazar K; Kechrid F; Zribi M; Masmoudi A; Fendri C
Microb Drug Resist; 2017 Jun; 23(4):468-472. PubMed ID: 27802107
[TBL] [Abstract][Full Text] [Related]
26. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
[TBL] [Abstract][Full Text] [Related]
27. Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs.
Mezzatesta ML; Caio C; Gona F; Cormaci R; Salerno I; Zingali T; Denaro C; Gennaro M; Quattrone C; Stefani S
Int J Antimicrob Agents; 2014 Aug; 44(2):112-6. PubMed ID: 25059444
[TBL] [Abstract][Full Text] [Related]
28. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
Rodríguez-Avial C; Rodríguez-Avial I; Merino P; Picazo JJ
Clin Microbiol Infect; 2012 Jan; 18(1):61-6. PubMed ID: 21722259
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of in vitro methods for testing tigecycline combinations against carbapenemase-producing Klebsiella pneumoniae isolates.
Papoutsaki V; Galani I; Papadimitriou E; Karantani I; Karaiskos I; Giamarellou H
J Glob Antimicrob Resist; 2020 Mar; 20():98-104. PubMed ID: 31398495
[TBL] [Abstract][Full Text] [Related]
30. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
31. Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli.
Docobo-Pérez F; Nordmann P; Domínguez-Herrera J; López-Rojas R; Smani Y; Poirel L; Pachón J
Int J Antimicrob Agents; 2012 Mar; 39(3):251-4. PubMed ID: 22154856
[TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamic Evaluation of the Potential Clinical Utility of Fosfomycin and Meropenem in Combination Therapy against KPC-2-Producing Klebsiella pneumoniae.
Albiero J; Sy SK; Mazucheli J; Caparroz-Assef SM; Costa BB; Alves JL; Gales AC; Tognim MC
Antimicrob Agents Chemother; 2016 Jul; 60(7):4128-39. PubMed ID: 27139468
[TBL] [Abstract][Full Text] [Related]
33. Triple combination of meropenem, colistin and tigecycline was bactericidal in a dynamic model despite mere additive interactions in chequerboard assays against carbapenemase-producing Klebsiella pneumoniae isolates.
Tsala M; Vourli S; Georgiou PC; Pournaras S; Daikos GRL; Mouton JW; Meletiadis J
J Antimicrob Chemother; 2019 Feb; 74(2):387-394. PubMed ID: 30376071
[TBL] [Abstract][Full Text] [Related]
34. In vitro synergy and postantibiotic effect of colistin combinations with meropenem and vancomycin against Enterobacteriaceae with multiple carbapenem resistance mechanisms.
Bedenić B; Car H; Slačanac D; Sviben M; Čačić M; Lukić-Grlić A; Benčić A; Šijak D; Tripković M; Beader N
J Infect Chemother; 2018 Dec; 24(12):1016-1019. PubMed ID: 30006247
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Park YJ; Yu JK; Park KG; Park YG; Lee S; Kim SY; Jeong SH
Diagn Microbiol Infect Dis; 2011 Sep; 71(1):87-9. PubMed ID: 21397426
[TBL] [Abstract][Full Text] [Related]
36. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility.
Roy S; Datta S; Viswanathan R; Singh AK; Basu S
J Antimicrob Chemother; 2013 May; 68(5):1036-42. PubMed ID: 23335112
[TBL] [Abstract][Full Text] [Related]
37. Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae.
Kádár B; Kocsis B; Tóth Á; Damjanova I; Szász M; Kristóf K; Nagy K; Szabó D
Acta Microbiol Immunol Hung; 2013 Jun; 60(2):201-9. PubMed ID: 23827751
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
[TBL] [Abstract][Full Text] [Related]
39. The plasmid-mediated fosfomycin resistance determinants and synergy of fosfomycin and meropenem in carbapenem-resistant Klebsiella pneumoniae isolates in Taiwan.
Tseng SP; Wang SF; Ma L; Wang TY; Yang TY; Siu LK; Chuang YC; Lee PS; Wang JT; Wu TL; Lin JC; Lu PL
J Microbiol Immunol Infect; 2017 Oct; 50(5):653-661. PubMed ID: 28705769
[TBL] [Abstract][Full Text] [Related]
40. Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals.
Mezzatesta ML; Gona F; Caio C; Petrolito V; Sciortino D; Sciacca A; Santangelo C; Stefani S
Clin Microbiol Infect; 2011 Sep; 17(9):1444-7. PubMed ID: 21668577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
